Cite
HARVARD Citation
Alton, E. et al. (n.d.). P96 Repeat Administration of GL67A/pGM169 is Feasible, Safe, and Produces Endogenous Levels of CFTR Expression After 12 Doses. Thorax. p. A105. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Alton, E. et al. (n.d.). P96 Repeat Administration of GL67A/pGM169 is Feasible, Safe, and Produces Endogenous Levels of CFTR Expression After 12 Doses. Thorax. p. A105. [Online].